AU2001245552A1 - Transcutaneous immunization for large particulate antigens - Google Patents

Transcutaneous immunization for large particulate antigens

Info

Publication number
AU2001245552A1
AU2001245552A1 AU2001245552A AU4555201A AU2001245552A1 AU 2001245552 A1 AU2001245552 A1 AU 2001245552A1 AU 2001245552 A AU2001245552 A AU 2001245552A AU 4555201 A AU4555201 A AU 4555201A AU 2001245552 A1 AU2001245552 A1 AU 2001245552A1
Authority
AU
Australia
Prior art keywords
large particulate
transcutaneous immunization
particulate antigens
antigens
transcutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001245552A
Inventor
Richard W. Compans
Zhiyi Sha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Publication of AU2001245552A1 publication Critical patent/AU2001245552A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001245552A 2000-03-09 2001-03-09 Transcutaneous immunization for large particulate antigens Abandoned AU2001245552A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18811200P 2000-03-09 2000-03-09
US60188112 2000-03-09
PCT/US2001/007557 WO2001066700A1 (en) 2000-03-09 2001-03-09 Transcutaneous immunization for large particulate antigens

Publications (1)

Publication Number Publication Date
AU2001245552A1 true AU2001245552A1 (en) 2001-09-17

Family

ID=22691815

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001245552A Abandoned AU2001245552A1 (en) 2000-03-09 2001-03-09 Transcutaneous immunization for large particulate antigens

Country Status (3)

Country Link
US (1) US20010036463A1 (en)
AU (1) AU2001245552A1 (en)
WO (1) WO2001066700A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE471990T1 (en) 2001-08-13 2010-07-15 Univ Rochester TRANSCUTANE IMMUNIZATION AGAINST PAPILLOMAVIRUS WITH VIRUS-LIKE PAPILLOMAVIRUS PARTICLES
US20040137004A1 (en) * 2002-03-19 2004-07-15 Glenn Gregory M Patch for transcutaneous immunization
WO2009023311A2 (en) * 2007-05-07 2009-02-19 Alba Therapeutics Corporation Transcutaneous delivery of therapeutic agents
PL222497B1 (en) 2009-06-26 2016-08-31 Inst Biochemii I Biofizyki Pan Virus-like vector particle, process for preparation and use thereof and pharmaceutical composition containing the virus-like vector particle
CA3058474A1 (en) 2017-04-03 2018-10-11 Sivec Biotechnologies, Llc A transkingdom platform for therapeutic nucleic acid delivery

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE180407T1 (en) * 1993-01-11 1999-06-15 Dana Farber Cancer Inst Inc INDUCTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5686113A (en) * 1995-03-21 1997-11-11 Temple University Of The Commonwealth System Of Higher Education Microcapsules of predetermined peptide(s) specificity (ies), their preparation and uses
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization

Also Published As

Publication number Publication date
US20010036463A1 (en) 2001-11-01
WO2001066700A1 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
AU2002222112A1 (en) Hybrid antibodies
AU1290001A (en) Antibodies
AU2002256895A1 (en) Anti-TRAIL-R antibodies
AU7912100A (en) Pharmaceutical composition comprising an antigen
AU4935000A (en) Antibodies
AU1951201A (en) Peptide antigens
AU2001238677A1 (en) Method for preparing anti-mif antibodies
AU2002365649A1 (en) Anti-dota antibody
AU2001290860A1 (en) Spas-1 cancer antigen
AU2002349543A1 (en) Tumor antigens
AU2977500A (en) Advanced antigen presentation platform
AU6278300A (en) Tumor-associated antigen (r11)
AU2001251394A1 (en) Immunological methodology for discerning human papillomavirus
AU2994599A (en) Active immunization against angiogenesis-associated antigens
AU2001245552A1 (en) Transcutaneous immunization for large particulate antigens
AU2001259077A1 (en) Immunomodulatory methods using carbohydrate antigens
AU3283500A (en) Tumor-associated antigen
AU2001295582A1 (en) Tumour-related antigens
AU2452301A (en) Protein methylarginine-specific antibodies
AU2002221132A1 (en) Novel antibody
AU2001261534A1 (en) The meca-79 antigen and related methods
AU7788600A (en) Colon-tumour-associated antigens
AU2002304681A1 (en) Haemophilus influenzae antigens
GB9915419D0 (en) Antigens
AU2202801A (en) Antigen preparations